Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.
Total Global Data
Last Updated: January 14, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
LARGE PD - CETRAM
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Fundación Valle del Lili
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Hospital San Felipe
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Instituto de Neurociencias de Buenos Aires
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Instituto Nacional de Ciencias Neurológicas
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - TecSalud
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Universidad de Antioquia
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Universidad de Chile
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
LARGE PD - Universidad Nacional Autónoma de México
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).